- Article metrics
- Last updated: Fri, 26 Apr 2024 12:42:19 Z
Genomics to select treatment for patients with metastatic breast cancer
Access & Citations
-
- 18k
- Article Accesses
-
- 61
- CrossRef
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.
Online attention
- 244 tweeters
- 1 blogs
- 3 Facebook pages
- 8 news outlets
- 127 Mendeley
This article is in the 98th percentile (ranked 6,621st) of the 434,444 tracked articles of a similar age in all journals and the 70th percentile (ranked 316th) of the 1,063 tracked articles of a similar age in Nature
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
-
Diagnose Mammakarzinom – die Krankheit Brustkrebs besser verstehen
Mitteldeutscher Rundfunk -
Genomics to select treatment for patients with metastatic breast cancer – Nature
Alert Breaking News - US -
전이성 유방암 환자에 대한 치료법 선택을 위한 유전체학(Nature)
Nature Asia -
Molecular Pathology Abstracts
Cap Today -
New study presents hope for patients with chemo-resistant breast cancer
Front Line Genomics
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.